Bailey Gregory 4

What Happened

• Bailey Gregory, a director of Serina Therapeutics, received 59,667 shares of common stock on March 31, 2026. The shares were recorded at $1.94 per share for a total value of $115,754. This was an award/acquisition (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-03-31; Price per share: $1.94; Total value: $115,754
• Transaction type/code: Award/Acquisition (A)
• Filing date (Form 4): 2026-04-21 — this filing was late relative to the standard 2-business-day reporting requirement
• Shares owned after the transaction: Not disclosed in this filing
• Footnote: Shares were issued to pay accrued dividends on the reporting individual's Series A Convertible Preferred Stock issued April 8, 2025

Context

• These shares were issued in lieu of cash dividends on preferred stock, a corporate financing/capital-structure action rather than a market purchase or sale by the insider. Such issuances don’t necessarily indicate the insider’s view on the company’s stock price.